The client is teaching a patient about the black box warning for montelukast and includes which information?

A. This medication increases the side effects of albuterol: Montelukast is a leukotriene receptor antagonist used for asthma and allergic rhinitis. It does not potentiate or increase the side effects of beta-agonists such as albuterol. Concomitant use is generally safe and does not require additional monitoring for drug-drug interactions in this context. B. Monitor for a new allergy to peanuts: Montelukast is not associated with inducing food allergies, including peanuts. Patients do not need to monitor for new food sensitivities specifically while taking this medication. Allergic reactions are rare and not the primary concern addressed in the black box warning. C. Do not take this medication with alcohol: Alcohol does not significantly interact with montelukast, and there is no formal contraindication regarding its use. General caution with alcohol may apply for overall health but is unrelated to montelukast’s black box warning. D. Monitor for psychiatric side effects including suicidal thoughts: Montelukast carries a black box warning for potential neuropsychiatric events. Patients and caregivers should monitor for changes in mood, agitation, depression, or suicidal thoughts. Early recognition of these psychiatric side effects is critical, as prompt reporting to a healthcare provider can prevent severe outcomes.